CONGJING was interviewed by China's state broadcaster CCTV

Since the promulgation and implementation of the Outline of the Healthy China 2030 Plan, people's health has become an important symbol of national prosperity and national prosperity. Recently, Ms. Xu Qing, founder of CONGJING Group, visited the "Dialogue Brand" column of CCTV Discovery Journey Channel to explore the combination of innovative traditional Chinese medicine and medical industry integration to help the construction of "healthy China".

Subsequently, the provincial and ministerial health science education newspaper "Health Guide" under the "Health Guide", China Radio International under the "China China Network", Phoenix TV media Group under the "Phoenix network" and other media reprinted and reported.

At the beginning of its establishment in 1993, Hengpu Weiye Company under the CONGJING brand chose the track of "microwave digital communication", which laid a brand of reliable quality and stable performance, and then obtained the "Network access License" from the Ministry of Posts and Telecommunications and the Ministry of Radio, Film and Television in 1995 and 1998 respectively. With excellent products, Hengpu Weiye stood out in the military industry, received attention and favor from all parties, and was selected for the National Day military Parade communication support service in 1999 and was commended.

In 2000, Hengpu Company decided to transform itself. After four years of product design and development, safety risk analysis, registration testing, clinical effectiveness testing, etc., Hengpu research team independently developed the "tumor radio frequency hyperthermia machine" obtained the national Class III medical device registration certification, this breakthrough research not only broke the foreign technology blockade, After that, the company has been approved a number of Class II medical device registration certificates and more than 100 product patents (invention patent number: ZL200610161685.3, you can check more patents through the State Intellectual Property Office), which has improved the quality of domestic cancer medical services and met the medical needs of the majority of patients.

With the deepening of the national "healthy China" strategy, the issue of people's health has been placed in an increasingly important position, and the medical and health industry is ushering in unprecedented development opportunities. Under this background, Congjing Group closely focuses on the national strategy, takes "radiofrequency moxibustion" as the starting point, and actively explores the development road of "medical industry integration" combining medical knowledge and modern science and technology.
The development of modern medical technology not only benefits from our breakthroughs in medical theory and clinical practice, but also benefits from the progress of medical science and technology to a large extent. Congjing Group has always adhered to the innovation-driven development strategy, taken the market demand as the orientation, closely combined with the national "healthy China" strategy, and vigorously promoted the research and development and application of "RF moxibustion therapy" technology. Through unremitting efforts, the company has successfully developed the core technology of "RF moxibustion therapy" with independent intellectual property rights, realizing the integration of traditional medical knowledge and modern science and technology, providing a new path and opportunity for the rapid development of medical industry, and providing more safe and effective treatment means for the majority of patients.
CONGJING Group Company gives full play to the advantages of "RF moxibustion therapy" technology, and actively carries out clinical application and promotion. At present, the technology has been successfully applied in many fields such as acupuncture, rehabilitation, physiotherapy, and medical beauty, which not only provides more solutions for the health protection of ordinary people, but also injects new vitality into China's medical industry.